Carl Walkey - Net Worth and Insider Trading

Carl Walkey Net Worth

The estimated net worth of Carl Walkey is at least $236,008 dollars as of 2024-11-13. Carl Walkey is the Senior Vice President of Neoleukin Therapeutics Inc and owns about 67,624 shares of Neoleukin Therapeutics Inc (NLTX) stock worth over $236,008. Details can be seen in Carl Walkey's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carl Walkey has not made any transactions after 2021-06-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Carl Walkey

To

Carl Walkey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Carl Walkey owns 1 companies in total, including Neoleukin Therapeutics Inc (NLTX) .

Click here to see the complete history of Carl Walkey’s form 4 insider trades.

Insider Ownership Summary of Carl Walkey

Ticker Comapny Transaction Date Type of Owner
NLTX Neoleukin Therapeutics Inc 2021-06-16 Senior Vice President

Carl Walkey Latest Holdings Summary

Carl Walkey currently owns a total of 1 stock. Carl Walkey owns 67,624 shares of Neoleukin Therapeutics Inc (NLTX) as of June 16, 2021, with a value of $236,008.

Latest Holdings of Carl Walkey

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NLTX Neoleukin Therapeutics Inc 2021-06-16 67,624 3.49 236,008

Holding Weightings of Carl Walkey


Carl Walkey Form 4 Trading Tracker

According to the SEC Form 4 filings, Carl Walkey has made a total of 21 transactions in Neoleukin Therapeutics Inc (NLTX) over the past 5 years, including 0 buys and 21 sells. The most-recent trade in Neoleukin Therapeutics Inc is the sale of 30 shares on June 16, 2021, which brought Carl Walkey around $6,114.

Insider Trading History of Carl Walkey

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Carl Walkey Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Carl Walkey Ownership Network

Ownership Network List of Carl Walkey

No Data

Ownership Network Relation of Carl Walkey

Insider Network Chart

Carl Walkey Owned Company Details

What does Neoleukin Therapeutics Inc do?

Who are the key executives at Neoleukin Therapeutics Inc?

Carl Walkey is the Senior Vice President of Neoleukin Therapeutics Inc. Other key executives at Neoleukin Therapeutics Inc include 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Sean Michael Smith , and Chief Medical Officer Priti Patel .

Neoleukin Therapeutics Inc (NLTX) Insider Trades Summary

Over the past 18 months, Carl Walkey made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net purchase of 2,285,342 shares made by Baker Bros. Advisors Lp , and a net sale of 1,323 shares made by Sean Michael Smith .

In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 66 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 114,267 shares were bought by its insiders, resulting in a net purchase of 114,201 shares.

Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Neoleukin Therapeutics Inc Insider Transactions

No Available Data

Carl Walkey Mailing Address

Above is the net worth, insider trading, and ownership report for Carl Walkey. You might contact Carl Walkey via mailing address: C/o Neoleukin Therapeutics, Inc., 360-1616 Eastlake Avenue East, Seattle Wa 98102.